LKB1 loss of function studied in vivo

被引:19
|
作者
Shorning, Boris Y. [1 ]
Clarke, Alan R. [1 ]
机构
[1] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales
来源
FEBS LETTERS | 2011年 / 585卷 / 07期
关键词
LKB1; Animal model; In vivo; PEUTZ-JEGHERS-SYNDROME; ACTIVATED PROTEIN-KINASE; SERINE-THREONINE KINASE; LUNG-CANCER PATIENTS; SEX-CORD TUMOR; SOMATIC MUTATIONS; HAMARTOMATOUS POLYPOSIS; GLUCOSE-HOMEOSTASIS; TESTICULAR-TUMORS; CARDIAC-FUNCTION;
D O I
10.1016/j.febslet.2011.01.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent developments have placed the serine/threonine kinase LKB1 on the crossroads linking energy metabolism, cell structure and cancer progression and that its deletion can affect tumorigenesis, metastasis, cell adhesion and polarity. LKB1 can regulate a host of different functions which all have potential to impact upon the initiation and progression of neoplastic disease. To understand the phenotypic consequences of LKB1 loss in a range of different settings, a number of animal models of loss of function have been generated and analyzed. In this review we summarize recent data generated from a range of these models, which reveal clear tissue specific differences in LKB1 function in vivo and in the consequences of its loss. (C) 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:958 / 966
页数:9
相关论文
共 50 条
  • [41] Dysregulation of lung developmental pathways associated with LKB1 loss in lung cancer
    Kaufman, Jacob M.
    Lowe, Cindy
    Harris, Bradford
    Boyd, Kelli
    Amann, Joseph
    Eisenberg, Rosana
    Carbone, David
    Massion, Pierre
    CANCER RESEARCH, 2016, 76
  • [42] AMPK potentiation by LKB1 isoforms
    Thibert, Chantal
    Perret, Christine
    Billaud, Marc
    ONCOTARGET, 2015, 6 (34) : 35139 - 35140
  • [43] LKB1 as the ghostwriter of crypt history
    Marnix Jansen
    Danielle Langeveld
    Wendy W. J. De Leng
    Anya N. A. Milne
    Francis M. Giardiello
    G. Johan A. Offerhaus
    Familial Cancer, 2011, 10
  • [44] Insights into targeting LKB1 in tumorigenesis
    Trelford, Charles B.
    Shepherd, Trevor G.
    GENES & DISEASES, 2025, 12 (02)
  • [45] The LKB1/AMPK polarity pathway
    Mirouse, Vincent
    Billaud, Marc
    FEBS LETTERS, 2011, 585 (07) : 981 - 985
  • [46] LKB1/AMPK Signaling in the Diaphragm
    Brown, Jacob Daniel
    Mongillo, Anthony D.
    DiGiovanni, Ryan A.
    Lane, Matt D.
    Winder, William W.
    Thomson, David M.
    FASEB JOURNAL, 2009, 23
  • [47] A new mechanism for LKB1 activation
    Lee, Szu-Wei
    Lin, Hui-Kuan
    MOLECULAR & CELLULAR ONCOLOGY, 2018, 5 (03):
  • [48] Loss of LKB1 Expression Decreases the Survival and Promotes Laryngeal Cancer Metastasis
    He, Sha-sha
    Chen, Yong
    Wang, Hong-zhi
    Shen, Xiao-ming
    Sun, Peng
    Dong, Jun
    Liao, Xin-biao
    Guo, Gui-fang
    Chen, Ju-gao
    Xia, Liang-ping
    Hu, Pei-li
    Qiu, Hui-juan
    Liu, Shou-sheng
    Zhou, Yi-xin
    Wang, Wei
    Hu, Wei-han
    Cai, Xiu-yu
    JOURNAL OF CANCER, 2017, 8 (17): : 3548 - 3554
  • [49] Loss of LKB1 mediates an immune inert phenotype in human lung adenocarcinoma
    Denning, Warren L.
    Skoulidis, Ferdinandos
    Shen, Li
    Papadimitrakopoulou, Vassiliki
    Diao, Lixia
    Lou, Yanyan
    Byers, Lauren A.
    Wang, Jing
    Canales, Jaime R.
    VVistuba, Ignacio I.
    Weinstein, John
    Gibbons, Don L.
    Heymach, John V.
    CANCER RESEARCH, 2016, 76
  • [50] LKB1 in transmembrane receptor signaling
    Okon, Imoh S.
    Zou, Ming-Hui
    ONCOTARGET, 2015, 6 (19) : 16804 - 16805